To investigate whether B. infantis EVC001 colonization in the infant gut can reduce symptoms of colic
There is evidence to support that B. infantis EVC001 supplementation may ameliorate symptoms associated with colic by establishing and maintaining the necessary gut microbial composition to promote proper barrier and immune function in infants. The primary objective of this study is to assess the effect of the probiotic, B. infantis EVC001, on reducing the duration of crying/fussing symptoms of breastfed infants diagnosed with infantile colic from Baseline to Day 14.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
1
Infant probiotic
Obvio Health
Orlando, Florida, United States
Change in crying/fussing duration
Assess the effect of the probiotic, B. infantis EVC001, on duration of crying/fussing symptoms of breastfed infants diagnosed with infantile colic
Time frame: Baseline to Day 14
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.